BM
MNTA

Bridger Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bridger Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,670,000
Closed -$24M – 46
2013
Q3 		$24M Buy
1,670,000
+1,234,353
+283% +$18.9M 1.72% 27
2013
Q2 		$6.56M Buy
+435,647
New +$5.75M 0.48% 36

Other funds holding MNTA

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bridger Management's MNTA Position: Q4 2013 in Review

Bridger Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2013, closing a stake of 1,670,000 shares — an estimated $24M sold.

Bridger Management first reported a position in MNTA in Q2 2013 and held it in 2 quarters. The position peaked at $24M in Q3 2013. 133 funds tracked by Wall St. Rank hold MNTA as of Q4 2013.

  • Bridger Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2013 after selling out during the quarter.
  • Bridger Management sold 1,670,000 Momenta Pharmaceuticals, Inc. shares in Q4 2013, an estimated $24M.
  • Bridger Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 2 quarters.
  • Bridger Management's Momenta Pharmaceuticals, Inc. position peaked at $24M in Q3 2013.
  • 133 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2013.

Based on Bridger Management's 13F filing for Q4 2013, filed 14 Feb 2014.